Table 1 Normal weight obesity (NWO) and incident postmenopausal breast cancer by subgroups in the UK Biobank.

From: Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis

Subgroups

No. of participants

NWL

NWO

P-interactiona

Age

   

0.702

 <60 years

24,072

1.00

1.15 (0.98–1.34)

 

 ≥60 years

28,434

1.00

1.22 (1.07–1.38)

 

Ethnic

   

0.715

 White

50,526

1.00

1.19 (1.08–1.32)

 

 Others

1980

1.00

1.04 (0.59–1.80)

 

Smoking status

   

0.309

 Never

31,631

1.00

1.21 (1.06–1.38)

 

 Ever

16,299

1.00

1.19 (1.00–1.40)

 

 Current

4428

1.00

1.08 (0.77–1.51)

 

Drinking status

   

0.304

 Never

2591

1.00

1.46 (0.91–2.34)

 

 Ever

1626

1.00

1.04 (0.60–1.82)

 

 Current

48,243

1.00

1.17 (1.06–1.30)

 

Physical activity

   

0.396

 Low

5621

1.00

1.33 (1.01–1.74)

 

 Medium

17,713

1.00

1.08 (0.92–1.28)

 

 High

18,052

1.00

1.21 (1.01–1.45)

 

Educational level

   

0.927

 College or University degree

18,270

1.00

1.14 (0.96–1.36)

 

 A/AS levels or equivalent

6122

1.00

1.24 (0.95–1.64)

 

 O levels/GCSEs or equivalent

11,741

1.00

1.14 (0.94–1.40)

 

 Others

11,5577

1.00

1.28 (1.00–1.45)

 

Townsend Deprivation Index

   

0.780

 Low

17,483

1.00

1.20 (1.03–1.40)

 

 Intermediate

17,479

1.00

1.33 (1.13–1.58)

 

 High

17,486

1.00

1.00 (0.82–1.22)

 

Polygenic risk score

   

0.027

 Low

17,019

1.00

1.11 (0.87–1.42)

 

 Intermediate

17,019

1.00

1.06 (0.87–1.28)

 

 High

17,024

1.00

1.32 (1.13–1.48)

 

History of mammograms

   

0.855

 Yes

49,797

1.00

1.17 (1.06–1.29)

 

 No

2679

1.00

1.64 (0.93–2.87)

 

HRT use

   

0.358

 Yes

23,980

1.00

1.21 (1.06–1.40)

 

 No

28,409

1.00

1.15 (1.00–1.32)

 

Number of births

   

0.743

 Nulliparous

9594

1.00

1.21 (0.96–1.52)

 

 <3

30,934

1.00

1.14 (1.00–1.29)

 

 ≥3

11,978

1.00

1.33 (1.07–1.66)

 

Age at menarche, years

   

0.448

 <12

9370

1.00

1.21 (0.96–1.53)

 

 12–13

22,437

1.00

1.24 (1.07–1.45)

 

 ≥14

20,669

1.00

1.12 (0.96–1.31)

 

Age at menopause, years

    

 <50

20,840

1.00

1.30 (1.10–1.53)

0.772

 50–55

24,969

1.00

1.09 (0.95–1.26)

 

 ≥55

6687

1.00

1.26 (0.99–1.61)

 
  1. Cases with missing information were excluded.
  2. NWL normal weight lean, HRT Hormone replacement therapy.
  3. aModels were adjusted for age, gender, race, smoking status, drinking status, physical activity, education attainment, socioeconomic status, family history of breast cancer, history of mammograms, age at menarche, age at first live birth, number of births, hormone replacement therapy (HRT) use, oral contraceptives and age at menopause, with the exception of stratifying factors.